[{"address1": "11750 Sorrento Valley Road", "address2": "Suite 200", "city": "San Diego", "state": "CA", "zip": "92121", "country": "United States", "phone": "979 446 0027", "website": "https://ibioinc.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "iBio, Inc., a preclinical stage biotechnology company, engages in the development of artificial intelligence (AI) antibodies solutions for cancer, and other diseases. The company's technology platforms include EngageTx that provides improved CD3 T-cell engager antibody panel; ShieldTx, an antibody masking technology that enables the creation of conditionally activated antibodies; StableHu, an AI antibody-optimizing technology; and AI epitope steering technology that guides antibodies against the desired regions of the target protein. Its product pipelines for cardiometabolic disease area include IBIO-101, an anti-CD25 Mab that binds and depletes immunosuppressive regulatory treg cells to inhibit the growth of solid tumors; CCR8, an antibody that enhance the body's immune response against cancer cells; and trophoblast cell surface antigen 2, a monoclonal antibodies, as well as MUC16 and Target 5 antibodies. In addition, the company is developing EGFRvIII, an antibody therapeutics that targets EGFRvIII protein with the aim to address these cancer types without affecting healthy cells. It has a collaboration agreement with AstralBio to discover and develop novel antibodies for obesity and other cardiometabolic diseases. iBio, Inc. was incorporated in 2008 and is headquartered in San Diego, California.", "fullTimeEmployees": 20, "companyOfficers": [{"maxAge": 1, "name": "Dr. Martin B. Brenner D.V.M., Ph.D.", "age": 54, "title": "CEO, Chief Scientific Officer & Director", "yearBorn": 1970, "fiscalYear": 2024, "totalPay": 753000, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Felipe  Duran", "age": 45, "title": "Chief Financial Officer", "yearBorn": 1979, "fiscalYear": 2024, "totalPay": 513224, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Marc  Banjak J.D.", "title": "Chief Legal Officer", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Kristi  Sarno", "title": "Senior VP of Business Development", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}], "auditRisk": 9, "boardRisk": 6, "compensationRisk": 9, "shareHolderRightsRisk": 4, "overallRisk": 7, "governanceEpochDate": 1756684800, "compensationAsOfEpochDate": 1735603200, "executiveTeam": [], "maxAge": 86400, "priceHint": 4, "previousClose": 0.9631, "open": 0.93, "dayLow": 0.92, "dayHigh": 0.9595, "regularMarketPreviousClose": 0.9631, "regularMarketOpen": 0.93, "regularMarketDayLow": 0.92, "regularMarketDayHigh": 0.9595, "payoutRatio": 0.0, "beta": 0.862, "forwardPE": -0.5692073, "volume": 471184, "regularMarketVolume": 471184, "averageVolume": 2631156, "averageVolume10days": 571350, "averageDailyVolume10Day": 571350, "bid": 0.8824, "ask": 0.9846, "bidSize": 1, "askSize": 1, "marketCap": 18347568, "fiftyTwoWeekLow": 0.56, "fiftyTwoWeekHigh": 6.89, "priceToSalesTrailing12Months": 45.86892, "fiftyDayAverage": 0.753, "twoHundredDayAverage": 2.02875, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 13337603, "profitMargins": 0.0, "floatShares": 18608223, "sharesOutstanding": 19654600, "sharesShort": 2142846, "sharesShortPriorMonth": 553594, "sharesShortPreviousMonthDate": 1753920000, "dateShortInterest": 1756425600, "sharesPercentSharesOut": 0.109, "heldPercentInsiders": 0.02856, "heldPercentInstitutions": 0.16445999, "shortRatio": 1.16, "shortPercentOfFloat": 0.1091, "impliedSharesOutstanding": 19654600, "bookValue": 0.769, "priceToBook": 1.2139142, "lastFiscalYearEnd": 1751241600, "nextFiscalYearEnd": 1782777600, "mostRecentQuarter": 1751241600, "netIncomeToCommon": -18377000, "trailingEps": -1.75, "forwardEps": -1.64, "lastSplitFactor": "1:20", "lastSplitDate": 1701216000, "enterpriseToRevenue": 33.344, "enterpriseToEbitda": -0.748, "52WeekChange": -0.515625, "SandP52WeekChange": 0.16885936, "quoteType": "EQUITY", "currentPrice": 0.9335, "targetHighPrice": 6.0, "targetLowPrice": 1.6, "targetMeanPrice": 4.2, "targetMedianPrice": 5.0, "recommendationMean": 1.0, "recommendationKey": "strong_buy", "numberOfAnalystOpinions": 3, "totalCash": 8582000, "totalCashPerShare": 0.437, "ebitda": -17827000, "totalDebt": 3572000, "quickRatio": 1.423, "currentRatio": 1.592, "totalRevenue": 400000, "debtToEquity": 24.005, "revenuePerShare": 0.038, "returnOnAssets": -0.44786, "returnOnEquity": -1.01519, "grossProfits": 400000, "freeCashflow": -6648750, "operatingCashflow": -15304000, "revenueGrowth": 0.143, "grossMargins": 1.0, "ebitdaMargins": 0.0, "operatingMargins": -25.99, "financialCurrency": "USD", "symbol": "IBIO", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "regularMarketPrice": 0.9335, "regularMarketChangePercent": -3.07341, "corporateActions": [], "postMarketTime": 1757720955, "regularMarketTime": 1757707201, "exchange": "NCM", "messageBoardId": "finmb_33000", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EDT", "gmtOffSetMilliseconds": -14400000, "market": "us_market", "esgPopulated": false, "marketState": "CLOSED", "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1219152600000, "postMarketChangePercent": -0.385646, "postMarketPrice": 0.9299, "postMarketChange": -0.0036, "regularMarketChange": -0.0296, "regularMarketDayRange": "0.92 - 0.9595", "fullExchangeName": "NasdaqCM", "averageDailyVolume3Month": 2631156, "fiftyTwoWeekLowChange": 0.3735, "fiftyTwoWeekLowChangePercent": 0.6669643, "fiftyTwoWeekRange": "0.56 - 6.89", "fiftyTwoWeekHighChange": -5.9565, "fiftyTwoWeekHighChangePercent": -0.8645138, "fiftyTwoWeekChangePercent": -51.5625, "dividendDate": 1528675200, "earningsTimestampStart": 1758193140, "earningsTimestampEnd": 1758542400, "isEarningsDateEstimate": true, "epsTrailingTwelveMonths": -1.75, "epsForward": -1.64, "epsCurrentYear": -0.35, "priceEpsCurrentYear": -2.6671429, "fiftyDayAverageChange": 0.18049997, "fiftyDayAverageChangePercent": 0.23970778, "twoHundredDayAverageChange": -1.0952499, "twoHundredDayAverageChangePercent": -0.5398644, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "ipoExpectedDate": "2025-03-04", "averageAnalystRating": "1.0 - Strong Buy", "cryptoTradeable": false, "shortName": "iBio, Inc.", "longName": "iBio, Inc.", "displayName": "iBio", "trailingPegRatio": null, "__fetch_time": "2025-09-13"}]